Clinical Trial Update: Preliminary Study of Safety and Efficacy of Policosanol [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of policosanol in dyslipidemia and HIV infection has completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• HIV Infection

Drugs mentioned

• Policosanol (Policosanol)

Snippet

Sponsor: Rush University Medical Center | Conditions: Dyslipidemia, HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2013-07-15